Details for New Drug Application (NDA): 215132
✉ Email this page to a colleague
The generic ingredient in LIDOCAINE HYDROCHLORIDE is epinephrine; lidocaine hydrochloride. There are twenty-one drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the epinephrine; lidocaine hydrochloride profile page.
Summary for 215132
Tradename: | LIDOCAINE HYDROCHLORIDE |
Applicant: | Afaxys |
Ingredient: | lidocaine hydrochloride |
Patents: | 0 |
Pharmacology for NDA: 215132
Physiological Effect | Local Anesthesia |
Suppliers and Packaging for NDA: 215132
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
LIDOCAINE HYDROCHLORIDE | lidocaine hydrochloride | INJECTABLE;INJECTION | 215132 | ANDA | Afaxys Pharma LLC | 50102-400 | 50102-400-10 | 10 VIAL, MULTI-DOSE in 1 TRAY (50102-400-10) / 20 mL in 1 VIAL, MULTI-DOSE (50102-400-01) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 1% | ||||
Approval Date: | Jun 9, 2022 | TE: | AP | RLD: | No |
Complete Access Available with Subscription